MD - MEDNAX, Inc.
| Previous Close | 37.53 |
| Open | 37.41 |
| Bid | 33.80 x 1300 |
| Ask | 63.00 x 800 |
| Day's Range | 36.10 - 37.42 |
| 52 Week Range | 36.10 - 63.04 |
| Volume | 1,167,502 |
| Avg. Volume | 978,950 |
| Market Cap | 3.204B |
| Beta (3Y Monthly) | 0.48 |
| PE Ratio (TTM) | 9.74 |
| EPS (TTM) | 3.72 |
| Earnings Date | Feb 6, 2019 - Feb 11, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 45.15 |
- Business Wire•2 days ago
MEDNAX Announces Completion of $250 Million Accelerated Share Repurchase Program
MEDNAX, Inc. (MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric physician services, and management services, today announced that it has completed the $250 million accelerated share repurchase (ASR) program previously announced on September 4, 2018. Under the terms of the ASR, the Company repurchased approximately 5.9 million shares of its common stock at an average price of $42.47 per share. The ASR program was completed as part of the previously announced authorization by MEDNAX’s Board of Directors to repurchase up to $500 million of the Company’s common stock.
- Insider Monkey•7 days ago
Hedge Funds Aren’t Crazy About Mednax Inc. (MD) Anymore
Does Mednax Inc. (NYSE:MD) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions in profits […]
- Simply Wall St.•10 days ago
Here’s How P/E Ratios Can Help Us Understand MEDNAX Inc (NYSE:MD)
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use MEDNAX Inc's (NYSE:MD) P/E ratio Read More...
- Zacks•15 days ago
Mednax (MD) Up 4.1% Since Last Earnings Report: Can It Continue?
Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•18 days ago
MEDNAX and Unit Unveil Incubator for Better Patient Results
MEDNAX (MD) and its radiology arm launch MDR-AI Incubator to develop products for better patient care.
- Business Wire•18 days ago
MEDNAX to Present at Upcoming Investor Conferences
MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.
- Business Wire•19 days ago
MEDNAX Radiology Solutions Launches Artificial Intelligence Incubator to Stimulate Innovation While Driving Adoption in Radiology
MEDNAX, Inc. (MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, has launched the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator. The MDR-AI Incubator brings together radiologists, a rich clinical dataset, and a select group of technology partners that will stimulate innovation and product development in radiology, improving radiologist’s accuracy and efficiency and overall quality of patient care. There are currently 15 active partners at various levels of engagement that are already delivering value through production use of existing models within the MEDNAX Radiology Common Imaging Platform.
- Business Wire•20 days ago
CORRECTING and REPLACING MEDNAX Continues Its Expansion in Radiology with the Acquisition of Another Leading South Florida Radiology Practice
Third paragraph, second sentence of release should read: In addition, the group services the Bethesda Outpatient Imaging Center at Bethesda Health City and Bethesda Health Urgent Care. MEDNAX, Inc. (MD), a leading physician services and health solutions provider, today announced the acquisition of Bethesda Radiology Associates, Inc., a private radiology physician group based in Boynton Beach, Fla. The practice will integrate with Radiology Associates of South Florida, LLC, a MEDNAX-affiliated physician practice located in Miami and serving all of South Florida.
- Business Wire•25 days ago
MEDNAX Radiology Solutions and vRad to Exhibit at RSNA 2018 Annual Meeting Nov. 25-29
One of the nation’s largest radiology practices, recognized as a leader in radiology, launches Artificial Intelligence Incubator and Radiology Centers of Excellence programs;
- Thomson Reuters StreetEvents•last month
Edited Transcript of MD earnings conference call or presentation 1-Nov-18 2:00pm GMT
Q3 2018 MEDNAX Inc Earnings Call
- Business Wire•last month
MEDNAX Announces Closing of $500 Million of 6.250% Senior Notes Due 2027
MEDNAX, Inc. (MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $492.5 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.
- GlobeNewswire•last month
Report: Developing Opportunities within Mednax, Peabody Energy, NIC, Endologix, MobileIron, and QuinStreet — Future Expectations, Projections Moving into 2018
NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Markit•last monthSee what the IHS Markit Score report has to say about MEDNAX Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Moody's•last month
MEDNAX, Inc. -- Moody's assigns Ba2 rating to MEDNAX, Inc.'s new unsecured bonds
Moody's Investors Service ("Moody's") assigned a Ba2 rating to MEDNAX, Inc.'s $750 million of new unsecured notes. There is no change to the Ba2 Corporate Family Rating, the Ba2-PD Probability of Default Rating, the Ba2 rating on the unsecured bonds due 2023, or SGL-1 Speculative Grade Liquidity Rating. Ratings assigned: MEDNAX, Inc.
- Business Wire•last month
MEDNAX Launches Private Offering of $750 Million Senior Notes Due 2026
MEDNAX, Inc. (MD), announced today that it is proposing to issue $750.0 million aggregate amount of senior notes due 2026 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). If the offering is successfully completed, MEDNAX intends to use the net proceeds from the offering to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S. The Notes will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
Markit•last monthSee what the IHS Markit Score report has to say about MEDNAX Inc.
MEDNAX Inc NYSE:MD
- Business Wire•last month
MEDNAX to Present at Upcoming Investor Conferences
MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.
- Simply Wall St.•last month
Why You Should Care About MEDNAX Inc’s (NYSE:MD) Cash Levels
If you are currently a shareholder in MEDNAX Inc (NYSE:MD), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested. Read More...
- Zacks•last month
MEDNAX (MD) Q3 Earnings Fall Short of Estimates, Rise Y/Y
MEDNAX's (MD) Q3 earnings grow on the back of the company's operational efficiency as well as its various growth initiatives.
Motley Fool•last monthMednax Inc (MD) Q3 2018 Earnings Conference Call Transcript
MD earnings call for the period ending September 30, 2018.
- Zacks•last month
Mednax (MD) Lags Q3 Earnings and Revenue Estimates
Mednax (MD) delivered earnings and revenue surprises of -2.08% and -0.75%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•last month
Mednax: 3Q Earnings Snapshot
The Sunrise, Florida-based company said it had profit of 72 cents per share. Earnings, adjusted for amortization costs and stock option expense, were 94 cents per share. The results fell short of Wall ...
- Business Wire•last month
MEDNAX Reports Third Quarter GAAP EPS of $0.72; Adjusted EPS of $0.94
Announces Initiation of Process to Sell MedData
- Business Wire•last month
MEDNAX Announces Acquisition of Leading Tennessee Radiology Practice
MEDNAX, Inc. (MD), today announced the acquisition of Associates in Diagnostic Radiology, P.C., a private radiology physician group based in Chattanooga, Tenn. The practice will integrate with Radiology Alliance, P.C., a MEDNAX-affiliated physician practice located in Nashville. This marks the Company’s eighth radiology services practice acquisition, further establishing MEDNAX Radiology Solutions as an industry leader, an innovator in health care informatics and a pioneer in telemedicine. Associates in Diagnostic Radiology was established in 1974.
